MRI and MRI-guided biopsies — a new Cochrane review

Cochrane reviews are structured, systematic, focused reviews of evidence in the field of medicine that either support or do not support specific forms of diagnosis and management of patients with or suspected of having particular disorders. … READ MORE …

Prospective data on the use of MRI-guided vs. TRUS-guided biopsy

Two newly published papers in the November issue of the Journal of Urology address prospective studies of the use of differing forms of MRI-guided biopsy in the diagnosis of prostate cancer. … READ MORE …

New Phase I/II trial of InSightec’s MRI-guided focal ultrasound therapy

According to a media release issued yesterday by the City of Hope medical center in Los Angeles, they have become the first center in the USA to treat a patient with focused, MRI-guided, ultrasound technology using the InSightec system. … READ MORE …

MRgFUS in first-line management of low-risk prostate cancer

The London Health Sciences Center and the Lawson Clinical Research Institute in London, Ontario, Canada, have reported the first use of MRI-guided ultrasound ablation for the treatment of low-risk, prostate cancer. … READ MORE …

MRI-guided biopsies growing more common … but can we deal with the cost?

According to an article published on the Medscape Oncology web site earlier today, two paper presented at the European Congress of Radiology have provided further evidence of the potential of MRI-guided biopsies in the diagnosis of prostate cancer. … READ MORE …

MRI-guided focused ultrasound in focal treatment of low-risk, localized prostate cancer

In October last year, the US Food and Drug Administration approved the ExAblate MRI-guided focused ultrasound technology for the treatment of pain associated with cancer metastasis to bones, which is obviously a potential benefit for men with late stage, metastatic prostate cancer. … READ MORE …

Are MRI-targeted biopsies “better” than standard 12-core TRUS-guided biopsies?

We often see recommendations that MRI-guided biopsies may be more accurate that transrectal ultrasound (TRUS)-guided biopsies in the diagnosis of prostate cancer. A new systematic review has attempted to assess the current status of data supporting or refuting this recommendation. … READ MORE …